Clinical Trial Update: Pilot Study Comparing Tiotropium (Spiriva) to Salmeterol (Serevent) Plus Fluticasone (Flixotide) in Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]

View source ↗

Summary

A Phase 4 pilot trial compares tiotropium alone to a combination of salmeterol and fluticasone for chronic obstructive pulmonary disease; the study has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Fluticasone (Flixotide) (fluticasone)
• Salmeterol (Serevent) (salmeterol)
• Tiotropium (Spiriva) (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED